Tominaga A, Wada K, Kato Y, Nishi H, et al. Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study. Osteoporos Int 2020 Sep 26. pii: 10.1007/s00198-020-05639.
PMID: 32979066